Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics Market Cap : 284.52M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 286.43M |
| November 16, 2026 | 283.38M |
| November 13, 2026 | 287.96M |
| November 12, 2026 | 281.09M |
| November 11, 2026 | 285.67M |
| November 10, 2026 | 284.14M |
| November 09, 2026 | 283.78M |
| November 06, 2026 | 282.26M |
| November 05, 2026 | 280.73M |
| November 04, 2026 | 287.60M |
| November 03, 2026 | 285.31M |
| November 02, 2026 | 278.44M |
| October 30, 2026 | 283.02M |
| October 29, 2026 | 287.60M |
| October 28, 2026 | 286.07M |
| October 27, 2026 | 282.26M |
| October 26, 2026 | 277.68M |
| October 23, 2026 | 280.73M |
| October 22, 2026 | 280.73M |
| October 21, 2026 | 282.26M |
| October 20, 2026 | 283.78M |
| October 19, 2026 | 282.26M |
| October 16, 2026 | 278.44M |
| October 15, 2026 | 279.97M |
| October 14, 2026 | 279.97M |
| Date | Value |
|---|---|
| October 13, 2026 | 280.73M |
| October 12, 2026 | 286.07M |
| October 09, 2026 | 287.60M |
| October 08, 2026 | 286.07M |
| October 07, 2026 | 279.97M |
| October 06, 2026 | 281.49M |
| October 05, 2026 | 283.02M |
| October 02, 2026 | 281.49M |
| October 01, 2026 | 280.73M |
| September 30, 2026 | 282.26M |
| September 29, 2026 | 282.26M |
| September 28, 2026 | 283.78M |
| September 25, 2026 | 285.31M |
| September 24, 2026 | 288.74M |
| September 23, 2026 | 290.65M |
| September 22, 2026 | 292.94M |
| September 21, 2026 | 289.88M |
| September 18, 2026 | 286.83M |
| September 17, 2026 | 287.60M |
| September 16, 2026 | 289.12M |
| September 15, 2026 | 288.36M |
| September 14, 2026 | 289.12M |
| September 11, 2026 | 289.88M |
| September 10, 2026 | 289.88M |
| September 09, 2026 | 292.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 18.69M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0407M |
| Arvinas, Inc. | 443.44M |
| Definium Therapeutics, Inc. | 3.986B |
Market Cap Related Metrics
| Price to Book Value | 0.9421 |
| Price | 3.725 |
| Earnings Yield | -28.02% |